Bandingkan Harga & Kinerja Fajar Surya Wisesa Tbk. (FASW) vs Indofarma Tbk. (INAF)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Fajar Surya Wisesa Tbk. dan Indofarma Tbk.: Fajar Surya Wisesa Tbk. diperdagangkan di Rp5.275 (kapitalisasi pasar 16,99 T), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Fajar Surya Wisesa Tbk. jauh lebih besar — sekitar 43,5× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| FASW | INAF | |
|---|---|---|
Kapitalisasi Pasar | 16,99 T | 390,51 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Fajar Surya Wisesa Tbk.
PT Fajar Surya Wisesa Tbk (the Company) was established based on Notarial Deed No. 20 dated June 13, 1987 of Lenny Budiman, S.H., notary in Jakarta.
Selengkapnya di halaman FASW →Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →
